Market Size Estimation:
This study's market size estimations and forecasts are the result of combining a top-down (evaluation of utilization/adoption/penetration trends by polymer type, functionality, type, end user, and region) and bottom-up (segmental analysis of important segments) methodology.
Projected Surge in Revenue Generation:
With a compound annual growth rate (CAGR) of 5.6%, the tablet coatings market is expected to reach a valuation of USD 969 million by 2025 from its estimated USD 739 million in 2020.
Major Growth Boosting Factors:
The pharmaceutical industry's growth and the rise in R&D in this area are the main factors driving this market's expansion. The market is expanding thanks to the burgeoning nutraceutical business, the fast expanding biopharmaceuticals sector, the growing generics market, and the increased use of orphan medications. Furthermore, there are a lot of prospects for market expansion due to the pharmaceutical industry's growing emphasis on emerging markets and the growing outsourcing of operations to these nations. The growing emphasis on technology developments in specialized markets also presents large growth prospects for companies involved in this industry.
However, throughout the projected period, the market's expansion is anticipated to be constrained by the tightening regulations pertaining to the licensing of pharmaceuticals and excipients, as well as the high cost of the microencapsulation process.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150774403
Data Triangulation:
The entire tablet coatings market was split into a number of categories and subsegments when the market size was determined. In order to finalize the market engineering process and obtain precise statistics for every segment and subsegment, data triangulation and market breakdown techniques were utilized, if appropriate.
End Users:
The pharmaceutical industry end-user segment is expected to account for the largest share of the tablet coatings market
The tablet coatings market, by end-user, is segmented into pharmaceutical and nutraceutical industry. The pharmaceutical industry segment accounted for the largest market share in 2019. The demand for tablet coatings in the pharmaceutical industry is largely driven by the increasing number of drugs launched as tablet formulations and growing prevalence of diseases for which tablet-based formulations form the primary treatment. The rising demand for innovative drug delivery formulations is also supporting the growth of the tablet coatings market for the pharmaceutical industry.
Geographical Growth Dynamics:
Asia Pacific is expected to account for the highest CAGR for players operating in the tablet coatings market
The Asia Pacific tablet coatings market is expected to grow at the highest CAGR from 2020 to 2025. Increase in outsourcing of drug manufacturing to specialized contract manufacturing organizations (CMOs), rising number of companies setting up manufacturing units in these countries, favorable government regulations, low labor and manufacturing costs, and the large base for the generation of generics & biologics are factors expected to drive the growth of the market during the forecast period.
Global Key Players:
The prominent players in this market are Colorcon Inc. (US), Sensient Technologies Corporation (US), BASF SE (Germany), Evonik Industries AG (Germany), Ashland Global Holdings Inc. (US), DuPont De Numeours Inc. (US), Kerry Group plc (Ireland), Roquette Freres (France), Eastman Chemical Company (US), Air Liquide S.A. (France), and Merck KGaA (Germany).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=150774403
Wednesday, April 10, 2024
Tablet Coatings Market - Emerging Trends to Bring Major Revolution in Global Healthcare Industry
Thursday, March 28, 2024
Contrast Media Market: A Major Revenue Surge is Predicted at a CAGR of 7.5% by 2029
Principal Growth-Inducing Factors:
Growing numbers of hospitals and diagnostic imaging facilities, increased awareness of early diagnosis, and an increase in the prevalence of chronic illnesses are the main factors driving market expansion. Conversely, the negative consequences linked to the usage of contrast media will limit this market's expansion somewhat.
Projected Surge in Global Revenue:
According to revenue estimates, the global contrast media market will be valued $6.3 billion in 2023 and is expected to rise at a compound annual growth rate (CAGR) of 7.5% to reach $9.7 billion by 2029.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
Global Industry Segmentation:
By application, the radiology segment held the biggest proportion of the contrast media market in 2022.
The contrast media market is divided into three segments based on application: interventional radiology, radiology, and interventional cardiology. By application, radiology held the biggest market share in 2022. radiological contributes to the increased demand for radiological operations by being essential in the early detection and monitoring of a variety of medical problems. The growing number of elderly people, the occurrence of chronic illnesses, and the need for minimally invasive procedures are just a few of the reasons for the high percentage of radiology applications.
By route of administration, the intravascular route segment held the biggest proportion of the contrast media market in 2022.
The global contrast media market is divided into intravascular, oral, rectal, and other routes of administration based on the mode of administration. According to the mode of administration, the intravascular route segment had the biggest market share in 2022. The reason for the segment's expansion is because, in contrast to powdered forms, injectable contrast media are more readily available and require less time to administer.
End Users:
According to end users, the Hospitals, Clinics, and Ambulatory Surgical Centers segment held the highest share in the contrast media industry in 2022.
The contrast media market is divided into categories based on the end user, including diagnostic imaging facilities, hospitals, clinics, and ambulatory surgical centers. The global market share held by hospitals, clinics, and ambulatory surgery facilities was the highest in 2022. The need for contrast media is increased because hospitals often make larger investments in and keep a wider variety of cutting-edge imaging equipment, including CT scanners, MRI machines, and interventional radiology suites.
Geographical Growth Scenario:
The contrast media industry's largest share was held by North America in 2022.
There are four main regions that make up the contrast media market: North America, Europe, Asia Pacific, and the Rest of the World. With the most market share in 2022, North America emerged as the top contributor. The number of product approvals in the region has increased as a result of the presence of significant businesses. These North American-based businesses have a wealth of experience, resources, and established sales networks, which help explain the region's market supremacy.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
Global Leading Companies:
The major players operating in this market are GE HealthCare (US), Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging (US), Unijules Life Sciences Ltd. (India), JB Pharma (India), Sanochemia Pharmazeutika (Germany), TAEJOON PHARM Co., Ltd. (South Korea), Jodas Expoim (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), Fresenius Kabi (Germany), Biem Ilaç San. ve Tic. A.S. (Turkey), and AdvaCare (US).
Wednesday, March 27, 2024
Cell Isolation Market - Future Revenue Growth Looks More Promising Due to These Factors
Market Size Estimation:
Top-down approach was used to estimate and validate the total size of the cell isolation market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The key players in the industry and market have been identified through extensive secondary research
The revenues generated from the cell isolation products business of leading players have been determined through primary and secondary research
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Projected Revenue Surge, Globally:
According to revenue estimates, the global cell isolation market will be valued $4.4 billion in 2023 and is expected to increase at a compound annual growth rate (CAGR) of 13.4% from 2023 to 2028, when it reaches $8.2 billion. The market's industry trends are analyzed in the latest research study.
Major Growth Driving Factors:
The market is expanding due to factors like the rise in cell-based research and the growing emphasis on personalized therapy. However, the main things impeding the growth of this market are high cost, safety concerns, and ethical considerations.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
Data Triangulation:
Following the completion of the market size assessment process, the entire market was divided into a number of segments and sub-segments. Data triangulation and market breakdown processes were used where appropriate to finish the entire market engineering process and yield precise statistics for all segments and subsegments. Through an analysis of numerous variables and patterns from the supply and demand sides, the data was triangulated.
Driver: Government support for cell-based research has increased.
The crucial first stage in the development of cell-based therapies is cell isolation. Because cell-based research has many applications, funding for these kinds of studies has been provided by numerous governments worldwide. The National Institutes of Health (NIH), for example, stated in May 2021 that funding totaling USD 30.0 million will be given to assist research targeted at creating new instruments and technology for researching cells. A number of US universities, including Harvard University, the University of California, San Francisco, and the University of Texas Southwestern Medical Center, received financing. Moreover, the Stem Cell Therapies Mission is investing USD 150.0 million over a ten-year period under the Medical Research Future Fund (MRFF) of the Government.
RESTRAINT: Ethics and safety concerns will impede commercial expansion
The embryo from which the cells are formed must be destroyed in order to isolate the embryonic stem cells. Given that some people believe an embryo to be a potential human person, this creates ethical questions regarding the taking of human life. Teratomas are tumors that comprise cells from all three germ layers, and they can be formed by embryonic stem cells. Without adequate screening, embryonic stem cells put into a patient have the potential to develop into tumors and cause damage. As a result, these elements may hinder market expansion to some degree.
Opportunity: Prospects for expansion in developing economies
The biopharmaceutical sector is expanding quickly in emerging nations like China, India, and Brazil. This is caused by a number of causes, including rising healthcare costs, an aging population, and an increase in chronic illnesses. The necessity for cell separation technologies is driving the development and manufacturing of biopharmaceuticals, as these markets see an increase in demand for these goods. Furthermore, growing markets are funding the creation and use of cutting-edge technologies including flow cytometry, magnetic cell separation, and microfluidics.
As a result, cell isolation procedures are becoming more accurate and efficient, and these technologies are becoming more widely available and reasonably priced in these markets. Additionally, there is an increasing trend in emerging markets for R&D activity. In these areas, public and private organizations are funding research to create novel cures and treatments for long-term illnesses. Since cell isolation is a crucial stage in the creation of various treatments, the market is expanding as a result of the expansion of research efforts in these areas.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
North America dominated cell isolation market in 2022.
Geographically, the market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for cell isolation in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including technical development, expansion of the biotechnology and pharmaceutical industries, and rising incidence of infectious and chronic diseases, account for the major share of the American market.
Leading Companies Operating in This Industry
Key players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).
Healthcare IT Market - Major Revenue Surge is Predicted in the Near Future
Market Size Estimation:
The total size of the healthcare IT market was arrived at after data triangulation from different approaches, as mentioned below. After each approach, the weighted average of approaches was taken based on the level of assumptions used.
Projected Surge in Revenue Generation:
Revenue-wise, the worldwide healthcare IT market was projected to be valued at $394.6 billion in 2022 and is expected to rise at a compound annual growth rate (CAGR) of 19.8% to reach $974.5 billion by 2027.
Major Growth Influencing Factors:
Instead of using numerous tables, the redesigned report edition presents each listed company's financial data until 2022 in a single diagram. This will make it simple to examine the current state of the organizations that have been profiled in terms of their R&D investments, business segment focus in terms of the top revenue-generating segments, financial strength, profitability, and important revenue-generating locations or nations. The increasing use of mHealth, telemedicine, e-prescribing, and other HCIT solutions is fueling the expansion of the healthcare IT sector. But security worries and interoperability problems are hindering the expansion of the worldwide market somewhat.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252
Data Triangulation:
The individual shares of each HCIT product & service, component, and end-user segment were determined by assigning weightages based on their utilization/adoption rate. Regional splits of the overall HCIT market and its subsegments are based on the adoption or utilization rates of the given products and services in the respective regions or countries.
Global Industry Segmentation:
By component, the services sector held the most proportion of the healthcare IT market.
Hardware, software, and services are the three component segments that make up the healthcare IT market. The services sector held the biggest market share in 2021. The advent of complicated software and the requirement for software integration and interoperability, which necessitates intensive training and frequent upgrades, are to blame for the services segment's growth. The requirement for software upgrades and updates due to the constantly evolving healthcare laws is also driving increased demand for HCIT services.
During the projection period, the healthcare provider solutions market had the highest growth, by type, in the clinical HCIT solutions segment.
In the healthcare IT market, the clinical HCIT solutions category is anticipated to grow at the fastest rate. One of the main factors propelling this market's expansion is the requirement to manage the escalating costs of healthcare and boost the effectiveness of healthcare services by lowering medical errors. However, the market's expansion is being hindered by high installation prices and a lack of qualified medical experts.
Geographical Growth Dynamics:
For the duration of the projection, Asia Pacific is anticipated to develop at the fastest rate.
Over the course of the projection period, the APAC market is anticipated to grow at the fastest rate. The APAC HCIT market is expanding due to a number of factors, including a sizable patient population—particularly in China and India—growing per capita income, increased healthcare industry investments by major participants in the market, and growing consumer awareness of cutting-edge technology.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=252
Key Players:
Optum (US), Cerner Corporation (US), Cognizant (US), Change Healthcare (US), Philips (US), Epic Systems Corporation (US), Dell Technologies (US), Allscripts (US), athenahealth (US), GE Healthcare (US), Oracle Corporation (US), Wipro (India), IBM(US), eClinicalWorks (US), Infor Systems (US), Conduent (US), Conifer (US), Nuance (US), 3M (US), SAS (US), Carestream Health (US), Inovalon (US), Practice Fusion, Inc. (US), InterSystems (US), and Tata Consultancy Services (India) are the major players in this market.
Different Growth Strategies Adopted by Them:
These companies are majorly focusing on the strategies such as acquisitions, product launches, agreements, collaborations, partnerships, and expansions in order to remain competitive and further increase their share in the market.
Neurovascular Devices Market - Future Revenue Growth Predictions by 2028
Overview of This Market:
The objective of the study is analyze the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies developments such as acquisitions, product launches, expansions, collaborations, agreements and partnerships of the leading players, the competitive landscape of the neurovascular devices market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were use to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.
Major Growth Driving Factors:
The rise in the prevalence of various neurovascular diseases, the growing popularity of minimally invasive surgical procedures, the development of the healthcare infrastructure in developing nations, and the strategic alliances and collaborations between research institutions and manufacturers to advance new advancements in interventional neurology are all factors contributing to the market's growth. The acceptance of neurovascular treatment is hampered, nevertheless, by the high cost of neurovascular interventional procedures and associated devices, particularly in developing nations with lax reimbursement rules.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847
Projected Surge in Revenue Generation:
The global neurovascular devices market in terms of revenue was estimated to be worth $3.6 billion in 2023 and is poised to reach $5.5 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028.
Market Segmentation:
Cerebral Aneurysms Segment is expected to account for the largest neurovascular devices market share in 2022, by disease pathology
Based on disease pathology, the neurovascular devices market is segmented into cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies (includes cavernous malformations and moyamoya disease). The cerebral aneurysm segment is anticipated to hold the largest market share of neurovascular devices market. The increasing market demand for neurovascular devices for aneurysm treatment can be attributed mainly to the presence of neuro-interventional devices for cerebral aneurysm such as embolic coils, increase in the technological advancement in the neurovascular devices, and rise in the cases of cerebral aneurysm globally.
The ambulatory care centers segment is anticipated to register highest CAGR during the forecast period.
The neurovascular devices market is divided into three segments based on the end user: hospitals and surgical centers, ambulatory care centers, and academic institutions and research labs. Over the course of the projection period, the ambulatory care centers segment is expected to exhibit the greatest CAGR. The ambulatory care centers segment is expected to grow in the coming years due to a number of factors, including an increasing number of ambulatory surgery centers in developed countries, ease of scheduling, clinical staff that is focused, improved productivity, increased safety, and efficacy of these centers, and growing preference for minimally invasive surgical procedures.
Geographical Growth Dynamics
North America to dominate the global neurovascular devices market
Based on the region, the neurovascular devices market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest share of neurovascular devices market. The large share of North America can be attributed to the high adoption of neurovascular devices in the region, the strong presence of device manufacturers, and the availability of significant R&D investments for product development.
Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to the presence of a large target patient population, rising awareness on the advantages of minimally invasive neurosurgical processes., geographical expansion of players in region, and government initiatives to modernize & expand healthcare infrastructure.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=847
Global Leading Companies:
The neurovascular devices market is dominated by players such Stryker (US), Johnson & Johnson (US), Medtronic plc (US), Terumo Corporation (Japan), and Penumbra, Inc. (US), among others.
Thursday, March 14, 2024
Human Microbiome Market - Major Revenue Surge is Predicted by 2029
Report Objectives:
# To define, describe, and forecast the human microbiome market based on products, type, application, and disease.
# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends).
# To strategically analyse micro markets with respect to individual growth trends, future prospects, and contributions to the overall human microbiome market.
# To analyse opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
# To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
# To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the human microbiome market.
Download PDF Brochure for More Details@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the human microbiome market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and market have been identified through extensive secondary research
# The revenues generated from the human microbiome business of leading players have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Projected Revenue Growth During Forecast Period:
The global human microbiome market in terms of revenue was estimated to be worth $0.3 billion in 2023 and is poised to reach $1.7 billion by 2029, growing at a CAGR of 36.1% from 2023 to 2029.
Major Growth Driving Factors:
The major factors driving the growth of the market are the surging demand for personalized medicine, and growing demand for natural and holistic approaches is expected to propel the growth of the market. However, limited understanding of microbial interactions are expected to restrain market growth to a certain extent.
Data Triangulation:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904
Global Geographical Segmentation:
Asia Pacific: The fastest-growing region in the human microbiome market.
The Asia Pacific human microbiome market is projected to grow at the highest CAGR during the forecast period, mainly due to increasing awareness of the importance of the microbiome in health and disease, the rising demand for personalized medicine, and advancements in sequencing technologies. The Asian market has also garnered significant attention from global players due to the increased focus on preventative healthcare and personalized medicine, driving the demand for human microbiomes.
Key Players:
The market for human microbiome is highly consolidated, with key players strategizing to capture the market. Prominent players in the human microbiome market are Seres Therapeutics, Inc. (US), Enterome (France), 4D pharma plc (UK), International Flavors & Fragrances Inc. (US), OptiBiotix Health Plc (UK), Ferring Pharmaceuticals (Switzerland), Synlogic, Inc. (US), Second Genome, Inc. (US), Vedanta Biosciences, Inc. (US), YSOPIA Bioscience (France), FlightPath Biosciences, Inc. (US), Finch Therapeutics Group, Inc. (US), AOBiome Therapeutics (US), BioGaia (Sweden), Quantbiome, Inc. (dba Ombre) (US), Viome Life Sciences, Inc. (US), BIOHM Health (US), DayTwo (US), Atlas Biomed (UK), Bione Ventures Private Limited (India), Luxia Scientific (France), Metabiomics (US), Sun Genomics (US), Seed Health (US), and Gnubiotics Sciences (Switzerland).
Dental Laboratories Market - Drivers, Restraints & Global Opportunities
Report Objectives:
# To define, characterize, and project the worldwide dental laboratory market according to prostheses, materials, equipment, and geography.
# To offer comprehensive details about the key elements (drivers, constraints, opportunities, and challenges) affecting the market's growth.
# To examine micromarkets in terms of their respective growth patterns, future potential, and market share contributions.
# To assess market opportunities for stakeholders and give important market players information about the competitive environment.
# To estimate market size in relation to the five key regions: Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa.
# To create a complete analysis of the core competencies and market shares of the major companies in the worldwide market with respect to important market developments, product portfolios, and financials.
# To monitor and assess competitive developments, including agreements of major participants in the worldwide market, partnerships, product launches, expansions, and mergers and acquisitions.
Download PDF Brochure for More Details@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223694318
Projected Revenue Growth During Forecast Period:
The market for dental laboratories worldwide Revenue was projected to be $35.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% to reach $46.5 billion by 2027.
Driver: An increase in the elderly population and instances of dentulism
The number of incidences of edentulism and the increase in the older population are driving demand in the market. The industry is growing as a result of the advancement of new technologies like as 3D printing and CAD/CAM, which enable the production of dental prostheses like veneers, crowns, bridges, and dentures that are customized for every patient. In addition, growing awareness of oral hygiene and the need for cosmetic dentistry operations are driving market expansion.
Restraint: high price of dental supplies and equipment
One major barrier to the market could be the high price of dental equipment and supplies. It's possible that many dental laboratories cannot afford the newest tools and materials needed to remain competitive. In the event that dental laboratories are underfunded or do not have access to financing, it may be difficult for them to make the investments in the newest equipment and materials needed to generate high-quality work. The financial burden of personnel training, equipment maintenance and repair, and other costs can also be very high for dental laboratories. Therefore, the high cost of dental supplies and equipment may limit the market's potential for expansion.
Opportunity: Rising demand for dental cosmetic procedures
In the upcoming years, it is expected that the global market for cosmetic dental procedures would grow significantly due to the growing demand. The primary causes of this growth include the advent of new technology, such as CAD/CAM systems and 3D printing for dental prostheses, as well as better access to dental care services and rising knowledge of oral hygiene. The growing need for cosmetic dentistry operations including veneers, crowns, implants, and bridges is another factor propelling the industry. Preventive dentistry is also driving market expansion as more people select examinations and treatments. Furthermore, the industry is expected to be further stimulated by the growing senior population and rising disposable incomes in emerging economies.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223694318
Global Geographical Segmentation:
Over the course of the projection period, the dental labs industry in APAC is expected to develop at the fastest rate.
In the Asia-Pacific region, dental laboratories accounted for almost 30% of the global market. The APAC market is expanding due to a number of factors, such as an aging population, a rise in dental tourism, a development in dental laboratories, and an increase in the outsourcing of various industrial services to the region. UN estimates indicate that 727 million individuals globally will be 65 years of age or older by 2020. There will be 1.5 billion older persons on the earth by 2050.
Dental lab product demand is expected to rise because this population is more prone to experience tooth loss and conditions like cavities and gum disease. The industry is also influenced by customer adoption of cutting-edge technology and need for improved aesthetics.